Pediatric-Onset Dystonia Associated with Bilateral Striatal Necrosis and G14459A Mutation in a Korean Family: A Case Report by Kim, In-Suk et al.
INTRODUCTION
Mitochondrial DNA (mtDNA) point mutations have been
associated with a wide range of clinical presentations, rang-
ing from pure myopathies to multi-systemic disorders. The
G14459A mtDNA mutation changes a moderately conserved
alanine residue to a valine within the most evolutionarily con-
served region of the ND6 gene, a component of complex I of
the mitochondrial electron transport chain (1). The G14459A
mutation has been associated with Leber hereditary optic neu-
ropathy (LHON)/pediatric-onset dystonia (2). Eight unre-
lated families have been identified with this mutation in indi-
viduals presenting with LHON, LHON plus dystonia, pedi-
atric-onset dystonia, and clinically asymptomatic phenotype
(2-7). In general, LHON presents as an adult-onset acute or
subacute visual loss. Pediatric-onset disease associated with
the G14459A mutation is characterized by dystonia, short
stature, bulbar and corticospinal tract dysfunction, and basal
ganglia degeneration on brain magnetic resonance imaging
(MRI). The typical age of onset is prior to 5 yr. 
Here, we present clinical and molecular data from a Korean
family with bilateral striatal necrosis and pediatric-onset dys-
tonia in whom we identified a homoplasmic G14459A muta-
tion in the ND6 gene of the mtDNA. The onset of proband
was a 5-yr-old boy and he was severely affected with dysarth-
ria, progressive, generalized dystonia, and spasticity. Brain
MRI demonstrated bilateral striatal necrosis. His younger
brother, younger sister, nephew, maternal uncle, and mater-
nal cousins had the same clinical features. His mother and
elder sister were asymptomatic. None of the family members
showed optic neuropathy.
CASE REPORT
A Korean family was enrolled in this study. The proband
(individual III-12), a younger sister (III-13), and a younger
brother (III-14) were a 34-yr-old man, a 32-yr-old woman,
and a 30-yr-old man, respectively, who had non-consangui-
neous parents (Fig. 1A). Their health was unremarkable until
5 yr of age, when they developed unilateral distal dystonic
posture and gait disturbances. The phenotype progressed and
they all currently showed severe dysarthria, contractures of
both ankle and wrist, both knee contractures, spasticity in
both lower extremity, spinal scoliosis, dystonic hands, and
generalized hypotonia, retropulsion, with mild mental retar-
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Pediatric-Onset Dystonia Associated with Bilateral Striatal Necrosis
and G14459A Mutation in a Korean Family: A Case Report 
We describe a Korean family presenting with pediatric-onset, progressive, gener-
alized dystonia with bilateral striatal necrosis and the homoplasmic G14459A muta-
tion in the mitochondrial ND6 gene. The G14459A mutation has been reported in
families presenting with Leber hereditary optic neuropathy (LHON) alone, LHON
plus dystonia, or pediatric-onset dystonia. The proband had shown dysarthria, pro-
gressive generalized dystonia, and spasticity at 5 yr. Brain MRI demonstrated bilat-
eral striatal necrosis. Additional investigation of family members revealed the pres-
ence of homoplasmic G14459A mutation in asymptomatic individuals. The clinical
manifestation of the homoplasmic G14459A mtDNA mutation within the same family
showed asymptomatic or pediatric-onset dystonia, without optic neuropathy. This
study reemphasizes that the G14459A mutation is a candidate mutation for mater-
nally inherited dystonia, regardless of optic neuropathy, and supports the hypothe-
sis that nuclear genes may play a role in modifying the clinical expression of mito-
chondrial disease. 
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dation. Their clinical features including time of onset were
very similar to those of the proband. The proband and younger
brother (III-14) was unable to communicate by phone because
of severe dysarthria. They could be ambulant by only wheel-
chair because of multiple joint contractures, spasticity of lower
extremity, and dystonia of foot. Vision and hearing were unaf-
fected. Brain MRI showed the presence of bilateral symmetric
tissue losses in both the putamen and caudate nucleus (Fig. 2).
An increase in lactic acid or amino acids levels in plasma was
not observed, and no abnormalities in plasma copper or ceru-
loplasmin levels were seen. Nerve conduction tests showed
no abnormality. The nephew (IV-3), a 6-yr-old boy, exhibit-
ed right hand dystonia, right ankle contractures and gait dis-
turbances. However, he was able to walk and swim by him-
self. He was normally delivered. His onset was at 5 yr old,
and it was also similar to that of proband. He was still nor-
mal in speech, intelligence, and stature. His MRI revealed
bilateral high signal intensity in T2-weighted images, with-
out necrosis (Fig. 2). The maternal uncle (II-3) and maternal
cousins (III-1 and III-2) suffered from progressive dystonia.
One maternal cousin (III-1) committed suicide in his third
decade. The proband’s mother (II-7), sister (III-11), and mater-
nal aunt (II-2) were asymptomatic. 
Genetic analysis
Six members (II-7, III-11, III-12, III-13, III14, and IV-3)
of the family were investigated by molecular genetic tests
(Fig. 1A). Four (III-12, III-13, III-14, and IV-3) had progres-
sive, generalized dystonia. Two (II-7, III-11) were asympto-
matic. After obtaining informed consent, genomic DNA was
isolated from peripheral blood leukocytes using a Wizard
genomic DNA purification kit (Promega, Madison, WI, USA),
according to the manufacturer’s protocol. The samples were
analyzed for the presence of 15 point mutations associated with
dystonia with bilateral striatal necrosis, LHON, or MELAS
(A3243G (7), T3271C, T3308C (8), G3460A, A8296G (9),
A8344G, T8356C, G8363A, T8851C (10), T8993G (11),
T9176C (11), G11778A, G14459A, T14484C, and T14487C
(12) by direct sequencing. In addition, the A3203G muta-
Fig. 2. Brain MRI of the proband (A, B) and his nephew (C, D). (A) The T2 weighted image of the proband show bilateral striatal hyperin-
tensities with necrosis. (B) The T1 weighted image of the proband show bilateral hypointensities with necrosis. (C) The T2 weighted image
of his nephew shows bilateral putaminal hyperintensities without necrosis. (D) The T1 weighted image of his nephew shows bilateral putami-
nal hypointensities without necrosis. 
Fig. 1. (A) Pedigree of a Korean family with maternally inherited, pediatric-onset dystonia carrying the G14459A mutation. (B) Direct sequenc-
ing analyses of the mitochondrial DNA for the G14459A mutation. Circle, female; square, male; black symbol, affected; dot, asymptomat-
ic carrier; diagonal line, deceased.
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tion, previously identified in a Japanese family, was analyzed
(7). The mitochondrial DNA was amplified by polymerase
chain reaction (PCR) using primers designed by the authors
(available upon request) and a thermal cycler (Model 9700;
Applied Biosystems, Foster City, CA, USA). Direct sequenc-
ing was performed using the BigDye Terminator Cycle Sequ-
encing Ready Reaction kit (Applied Biosystems) on an ABI
Prism 3100 genetic analyzer (Applied Biosystems). The direct
sequencing analysis revealed a homoplasmic G14459A muta-
tion in each of the patients examined (II-7, III-11, III-12,
III-13, III-14, and IV-3; Fig. 1B). Thus, two individuals (II-
7, III-11) were found to be asymptomatic carriers. 
DISCUSSION
The clinical features of the patients in this Korean family
included progressive, generalized dystonia, multiple joint con-
tracture, and spasticity, which were attributable to striatal
degeneration. In previous reports, the G14459A mutation
was observed in one Hispanic (2), five Caucasian (3-6), one
African-American (3), and one Japanese family (7) (Table 1).
The general features of previously reported cases were optic
neuropathy, progressive generalized dystonia, mild mental
retardation, and spasticity. In our family, pediatric-onset dys-
tonia, spasticity, and dysarthria were the major clinical pre-
sentations. Based on the clinical features between Caucasian
Hispanic Proband  2 yr Progressive  Normal Normal Bilateral lesions  Homoplasmic Pediatric onset  (2)
(IV-36) generalized  in the putamen and  dystonia
dystonia caudate nucleus
III-5 Not Asymptomatic Not  Normal Not  described Homoplasmic Asymptomatic
described described
III-10 32 yr Bilateral  Not Present Not described Heteroplasmic LHON
optic atrophy described
IV-25 Not  Optic atrophy Not  Present Not described Not described LHON plus 
described and dystonia described dystonia
IV-26 Not Optic atrophy Not Present Basal ganglia Homoplasmic LHON
described described lesions
IV-35 13 yr Mild dystonia  Delayed Normal Not described Homoplasmic Pediatric onset 
and intellectual  dystonia
impairment
V-11 5 yr Mild generalized  Not  Normal Basal ganglia Homoplasmic Pediatric onset 
dystonia described lesions dystonia
African Proband 42 yr Gradual, painless  Normal Present Not described Heteroplasmic LHON (3)
visual loss
Daughter 19 yr Gradual, painless Normal Present Unilateral lesion  Homoplasmic  LHON
visual loss in the right putamen
and bilateral lesions 
in the caudate nucleus
Caucasian Proband 34 months Generalized  Delayed  Normal Bilateral extensive Heteroplasmic Pediatric onset (3)
dystonia  lesions in basal  dystonia
and atherosis,  ganglia 
dysarthria
Caucasian Proband 18 yr Bilateral subacute Normal Present Lesions in dorsal  Heteroplasmic LHON plus  (4)
visual failure,  midbrain and dystonia
hearing loss, ataxia right red nucleus
Caucasian Proband  3 yr Stroke, dystonia Previously Normal Bilateral lesions Homoplasmic Pediatric onset  (5)
(IV-10) delayed in the putamen dystonia
III-6 35 yr Asymptomatic Normal Normal Bitemporal signal  Homoplasmic Asymptomatic
abnormalities, 
possible hematoma
IV-2 5 yr Limp Hemiparesis Normal Normal Bilateral lesions Homoplasmic Pediatric onset 
in the putamen dystonia
IV-8 7 yr Cognitive delay,  Delayed Normal Unilateral lesion Homoplasmic Pediatric onset
Hemiparesis in right sided putamen dystonia
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Table 1. Families reported as having maternally inherited dystonia with the G14459A mutation
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and non-Caucasian in Table 1, racial difference seemed to be
not apparent. The most striking difference in our family could
be no LHON manifestation such as visual disturbance or optic
nerve atrophy. Although delayed manifestation of visual dis-
turbance was reported in Japanese family, which was shown
at 38 yr, at least one person of their pedigree had visual distur-
bance or optic nerve atrophy in previous reports (2-7). Accord-
ingly, we don’t know whether any of our family members will
have delayed manifestation of optic neuropathy or not. 
Among the described cases (26/27) with the heteroplasmic
or homoplasmic G14459A mutation in Table 1, age at onset,
dystonia, impaired intelligence, and basal ganglia abnormali-
ty in neuroimmage was not statistically significant between
heteroplasmic and homoplasmic mutation groups (Table 2).
The heteroplasmic G14459A mutation has been associated
with heterogeneous clinical phenotypes, varying from asymp-
tomatic to dystonia, LHON, or dystonia plus LHON among
family members, while the homoplasmic G14459A muta-
tion has primarily been associated with pediatric-onset dys-
tonia, or asymptomatic phenotype (Table 2). Opthalmopa-
thy was more frequently noted in heteroplasmic type (6/9,
66.7%) than homoplasmic type (3/17, 17.6%), and this find-
ing was statistically significant (P<0.012; we regard P<0.05
as statistically significant). Even if, these are limited results
because it was done by literature review with inadequate des-
cribed information, heteroplasmic G14459A is more associ-
ated with LHON and homoplasmic G14459A is associated
with pediatric-onset dystonia. 
Although neither heteroplasmy nor homoplasmy for this
mutation is a direct predictor of LHON or a dystonia phe-
notype, many individuals are essentially homoplasmic for
the mutation. Thus, a threshold effect of the mtDNA muta-
tion may contribute to the phenotype of the mitochondrial
disease. However, a threshold effect could not explain why
some cases with homoplasmic mutation were asymptomat-
ic. Furthermore, the G14459A mtDNA mutation was also
Caucasian Proband  8 yr Seize up Normal Normal Bilateral lesions Heteroplasmic Pediatric onset  (6)
(II-1) Spasticity in the putamen dystonia
Progressive dystonia
II-2 19 yr Cecocentral scotoma Normal Present Not tested Heteroplasmic LHON
II-3 56 yr Asymptomatic Normal Normal Not tested Heteroplasmic Asymptomatic
Caucasian Proband 16 yr Deteriorated visual  Normal Present Normal  Heteroplasmic LHON (6)
activity
Japanese Proband 4 yr Progressive dystonia,  Gradually Present  Bilateral lesions Heteroplasmic  LHON plus (7)
(III-3) short stature deteriorated at 38 yr in the putamen G14459A combined dystonia
of A3203G
III-5 4 yr Progressive dystonia, Gradually Present Not tested Heteroplasmic  LHON plus
short stature deteriorated at 17 yr G14459A combined dystonia
of A3203G
Korean III-12  About  Progressive Delayed Normal Bilateral lesions Homoplasmic Pediatric onset This
(proband),  5 yr dystonia in the putamen and dystonia report
III-13, caudate  nucleus
III-14, 
IV-3
II-7 55 yr, Asymptomatic Normal Normal Not tested Homoplasmic Asymptomatic
III-11 36 yr
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Table 1. (Continued from the previous page) Families reported as having maternally inherited dystonia with the G14459A mutation
LHON, Leber hereditary optic neuropathy.
The statistical data were obtained using an SPSS software package, ver-
sion 11.5 (SPSS, Chicago, IL, USA). A cut-off P value of 0.05 was adopt-
ed for all the statistical analyses. 
LHON, Leber hereditary optic neuropathy; NS, statistically non-signifi-
cant.
Heteroplasmic
mutation
Parameters
Homoplasmic
mutation
P
value  
Number of cases 9 (34.4%) 17 (65.4%)
Mean age at onset  17.8 yr (3-56) 16.1 yr (2-55) NS
Dystonia 5 (55.6%) 10 (58.8%) NS
Impaired intelligence 3 (37.5%) 7 (46.7%) NS
Opthalmopathy 6 (66.7%) 3 (17.6%) 0.012
Basal ganglia degeneration  4 (44.4%) 12 (70.6%) NS
of neuro image
Clinical phenotype
Pediatric-onset dystonia 2 (22.2%) 10 (58.8%)
LHON 3 (33.3%) 0 (0%) 0.037
LHON plus dystonia 3 (33.3%) 3 (17.6%)
Asymptomatic 1 (11.1%) 4 (23.5%)
Table 2. The summary of clinical features of reported cases in
Table 1 according to the described heteroplasmic or homoplas-
mic G14459A mutation status184 I.-S. Kim, C.-S. Ki, and K.-J. Park
found in three unrelated families with Leigh disease (13). This
report adds to the clinical heterogeneity associated with the
G14459A mtDNA mutation. The heterogeneous clinical
features among the family members described here are unlike-
ly to have arisen from different secondary mtDNA mutations
among the family members because they were all from the
same maternal lineage. Therefore, these findings supports
that other nuclear modifier genes are involved in the patho-
genesis of the G14459A mutation (5). 
In summary, the G14459A mutation is a candidate muta-
tion for maternally inherited dystonia with bilateral striatal
necrosis, regardless of optic neuropathy. To our knowledge,
this is the first case revealing a mtDNA mutation in a Kore-
an family with a maternally inherited dystonia. Moreover,
the clinical manifestations of the homoplasmic G14459A
mtDNA mutation, even within the same family, are hetero-
geneous and support the hypothesis that nuclear genes may
play a role in modifying the clinical expression of mitochon-
drial disease. 
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